Testing effectiveness (Phase 2)Study completedNCT03328026
What this trial is testing
Combination Study of SV-BR-1-GM With Retifanlimab
Who this might be right for
Breast CancerBreast NeoplasmMetastatic Breast Cancer+1 more
BriaCell Therapeutics Corporation 36